| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Affordable Medicines | — | — | — | $414.71M | $433.43M | $460.74M | $436.65M | $423.24M |
| AvKARE | $170.41M | $159.49M | $170.39M | $172.42M | $163.04M | $198.53M | $210.74M | $166.02M |
| Specialty | $104.04M | $115.64M | — | $108.3M | $128.04M | $125.24M | — | $133.27M |
| Total | $701.78M | $702.47M | $730.52M | $695.42M | $724.51M | $784.51M | $814.32M | $722.52M |